RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.300
+0.030 (2.36%)
Jul 2, 2025, 4:00 PM - Market closed
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $47.54 million as of July 3, 2025. Its market cap has increased by 68.22% in one year.
Market Cap
47.54M
Enterprise Value
33.24M
1-Year Change
68.22%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $47.54M, a decrease of -30.74%. That is a compound annual growth rate of -9.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 47.54M | 53.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 694.34B |
| Johnson & Johnson | 375.01B |
| AbbVie | 338.94B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 286.74B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 233.54B |
| AstraZeneca | 221.11B |